SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

IM Cannabis Corp.
Date: July 2, 2025 · CIK: 0001792030 · Accession: 0000000000-25-007021

Offering / Registration Process Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288346

Date
July 2, 2025
Author
Division of
Form
UPLOAD
Company
IM Cannabis Corp.

Letter

Re: IM Cannabis Corp. Registration Statement on Form F-3 Filed June 26, 2025 File No. 333-288346 Dear Oren Shuster:

July 2, 2025

Oren Shuster Chief Executive Officer and Chairman of the Board IM Cannabis Corp. 3606-833 Seymour Street Vancouver, BC, V6B 0G4, Canada

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Daniel Crawford at 202-551-7767 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Eric Victorson, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 July 2, 2025

Oren Shuster
Chief Executive Officer and Chairman of the Board
IM Cannabis Corp.
3606-833 Seymour Street
Vancouver, BC, V6B 0G4, Canada

 Re: IM Cannabis Corp.
 Registration Statement on Form F-3
 Filed June 26, 2025
 File No. 333-288346
Dear Oren Shuster:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Daniel Crawford at 202-551-7767 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Eric Victorson, Esq.
</TEXT>
</DOCUMENT>